Arcoma AB (ARCOMA) — Cash Flow-to-Debt Ratio
Arcoma AB (ARCOMA) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2025, meaning its operating cash flow of Skr-308.00K could theoretically repay 0% of its total liabilities (Skr24.58 Million) in one year. Check Arcoma AB cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Arcoma AB Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Arcoma AB across 13 annual periods. Also explore ARCOMA current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Arcoma AB (2012–2024)
Year-by-year debt coverage analysis for Arcoma AB. For market capitalisation and broader financial context, see ARCOMA stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.89x | Skr18.84 Million | Skr21.13 Million | ▲ +55.0% |
| 2023 | 0.58x | Skr19.16 Million | Skr33.30 Million | ▲ +17602.3% |
| 2022 | 0.00x | Skr-179.00K | Skr54.46 Million | ▲ +94.0% |
| 2021 | -0.05x | Skr-1.93 Million | Skr35.23 Million | ▼ -136.4% |
| 2020 | 0.15x | Skr6.85 Million | Skr45.50 Million | ▼ -48.3% |
| 2019 | 0.29x | Skr11.10 Million | Skr38.14 Million | ▲ +23981.4% |
| 2018 | 0.00x | Skr45.00K | Skr37.24 Million | ▲ +100.4% |
| 2017 | -0.33x | Skr-8.91 Million | Skr27.28 Million | ▼ -137.3% |
| 2016 | -0.14x | Skr-4.67 Million | Skr33.90 Million | ▲ +4.5% |
| 2015 | -0.14x | Skr-4.95 Million | Skr34.34 Million | ▼ -552.4% |
| 2014 | -0.02x | Skr-828.00K | Skr37.48 Million | ▲ +89.1% |
| 2013 | -0.20x | Skr-11.82 Million | Skr58.35 Million | ▲ +12.5% |
| 2012 | -0.23x | Skr-10.27 Million | Skr44.35 Million | — |